These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 14946327)

  • 1. Development, persistence, and significance of type 2, poliomyelitis complement-fixing antibody in man.
    CASALS J; OLITSKY PK; SABIN AB
    J Exp Med; 1952 Jul; 96(1):35-53. PubMed ID: 14946327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A specific complement-fixation test for infection with poliomyelitis virus.
    CASALS J; OLITSKY PK; ANSLOW RO
    J Exp Med; 1951 Aug; 94(2):123-37. PubMed ID: 14861374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Homotypic complement-fixing antibody in monkeys infected with type 2 poliomyelitis virus by the oral route.
    CASALS J; OLITSKY PK; SABIN AB
    J Exp Med; 1952 Jul; 96(1):55-8. PubMed ID: 14946328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A complement fixation test for poliomyelitis.
    SCHMIDT NJ; LENNETTE EH
    J Exp Med; 1955 Aug; 102(2):133-50. PubMed ID: 13242739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complement-fixing antibodies to type 2 (Lansing) poliomyelitis virus in a normal population of a subtropical area.
    GOLDBLUM N; MELNICK JL
    J Exp Med; 1952 Aug; 96(2):175-85. PubMed ID: 14955573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Levels of homotypic neutralizing antibody in human poliomyelitis three years after infection.
    WINSSER J; SABIN AB
    J Exp Med; 1952 Nov; 96(5):477-90. PubMed ID: 13000058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody response of patients with poliomyelitis to virus recovered from their own alimentary tract.
    STEIGMAN AJ; SABIN AB
    J Exp Med; 1949 Oct; 90(4):349-72. PubMed ID: 18140667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ohio strains of a virus pathogenic for infant mice, Coxsackie group; simultaneous occurrence with poliomyelitis virus in patients with summer grippe.
    MELNICK JL; LEDINKO N
    J Exp Med; 1950 Feb; 91(2):185-95. PubMed ID: 15409906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IMMUNITY IN MUMPS : IV. THE CORRELATION OF THE PRESENCE OF COMPLEMENT-FIXING ANTIBODY AND RESISTANCE TO MUMPS IN HUMAN BEINGS.
    Maris EP; Enders JF; Stokes J; Kane LW
    J Exp Med; 1946 Sep; 84(4):323-39. PubMed ID: 19871573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transitory appearance of type 2 neutralizing antibody in patients infected with type 1 poliomyelitis virus.
    SABIN AB
    J Exp Med; 1952 Jul; 96(1):99-106. PubMed ID: 14946332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The intracellular localization of poliomyelitis virus.
    KAPLAN AS; MELNICK JL
    J Exp Med; 1953 Jan; 97(1):91-116. PubMed ID: 13022865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative studies of the virus-host relationship in chimpanzees after inapparent infection with Coxsackie viruses. I. The virus carrier state and the development of neutralizing antibodies.
    MELNICK JL; KAPLAN AS
    J Exp Med; 1953 Mar; 97(3):367-400. PubMed ID: 13052807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The growth curve of the Lansing strain of poliomyelitis virus in the central nervous system of the mouse.
    AINSLIE JD
    J Exp Med; 1952 Jan; 95(1):1-7. PubMed ID: 14907955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The adaptation of poliomyelitis virus, Lansing strain, to newborn mice and the use of their central nervous tissues for preparation of complement-fixing antigen.
    CASALS J; OLITSKY PK
    Arch Gesamte Virusforsch; 1951; 4(4):452-9. PubMed ID: 13249481
    [No Abstract]   [Full Text] [Related]  

  • 15. Some epidemiological aspects of poliomyelitis in Turkey; a serological survey for neutralizing and complement-fixing antibodies against polioviruses.
    PAYZIN S
    Bull World Health Organ; 1956; 15(1-2):339-54. PubMed ID: 13383369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The etiologic agents of varicella and herpes zoster; serologic studies with the viruses as propagated in vitro.
    WELLER TH; WITTON HM
    J Exp Med; 1958 Dec; 108(6):869-90. PubMed ID: 13598817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complement fixation test using the antigen prepared from the nervous tissue of adult mice infected with poliomyelitis virus Lansing type.
    ANDO K; ISHII K
    Jpn J Med Sci Biol; 1953 Feb; 6(1):91-105. PubMed ID: 13084302
    [No Abstract]   [Full Text] [Related]  

  • 18. IMMUNITY IN MUMPS : V. THE CORRELATION OF THE PRESENCE OF DERMAL HYPERSENSITIVITY AND RESISTANCE TO MUMPS.
    Enders JF; Kane LW; Maris EP; Stokes J
    J Exp Med; 1946 Sep; 84(4):341-64. PubMed ID: 19871574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IMMUNITY IN MUMPS : I. EXPERIMENTS WITH MONKEYS (MACACUS MULATTA). THE DEVELOPMENT OF COMPLEMENT-FIXING ANTIBODY FOLLOWING INFECTION AND EXPERIMENTS ON IMMUNIZATION BY MEANS OF INACTIVATED VIRUS AND CONVALESCENT HUMAN SERUM.
    Enders JF; Kane LW; Cohen S; Levens JH
    J Exp Med; 1945 Jan; 81(1):93-117. PubMed ID: 19871448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An epidemic of paralytic poliomyelitis characterized by dual infections with poliomyelitis and Coxsackie viruses.
    MELNICK JL; KAPLAN AS; ZABIN E; CONTRERAS G; LARKUM NW
    J Exp Med; 1951 Dec; 94(6):471-92. PubMed ID: 14897994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.